Abstract
107 patients have discontinued Hymenoptera venom immunotherapy between 1988 and 2000. 31 have been seen again with intradermal tests with IgEs, and 81 responded to a questionnaire. Intradermal reactions and IgEs decrease together significantly during immunotherapy and then persist at low level during three years. Beyond, the number of patients is insufficient. 32 patients were stung by the same Hymenoptera and not had any systemic reaction. However, five have beta blockers, three have IEC and half of the patients don't take precautions to avoid Hymenoptera.
MeSH terms
-
Adolescent
-
Adrenergic beta-Antagonists / therapeutic use
-
Adult
-
Animals
-
Anti-Allergic Agents / therapeutic use
-
Bee Venoms / adverse effects
-
Bee Venoms / immunology
-
Bee Venoms / therapeutic use*
-
Desensitization, Immunologic*
-
Female
-
Follow-Up Studies
-
Humans
-
Hymenoptera
-
Immunoglobulin E / blood
-
Insect Bites and Stings / drug therapy
-
Insect Bites and Stings / epidemiology
-
Insect Bites and Stings / immunology*
-
Intradermal Tests
-
Male
-
Middle Aged
-
Recurrence
-
Retrospective Studies
-
Surveys and Questionnaires
-
Treatment Outcome
-
Wasp Venoms / adverse effects
-
Wasp Venoms / immunology
-
Wasp Venoms / therapeutic use*
Substances
-
Adrenergic beta-Antagonists
-
Anti-Allergic Agents
-
Bee Venoms
-
Wasp Venoms
-
Immunoglobulin E